BR112013013283A2 - métodos para a radiorrotulação de uma molécula alvo biológica, e de preparação de uma composição radiofarmacêutica, precursor, uso de um aparelho sintetizador automatizado, cassete descartável, composto, e, uso de um composto - Google Patents
métodos para a radiorrotulação de uma molécula alvo biológica, e de preparação de uma composição radiofarmacêutica, precursor, uso de um aparelho sintetizador automatizado, cassete descartável, composto, e, uso de um compostoInfo
- Publication number
- BR112013013283A2 BR112013013283A2 BR112013013283A BR112013013283A BR112013013283A2 BR 112013013283 A2 BR112013013283 A2 BR 112013013283A2 BR 112013013283 A BR112013013283 A BR 112013013283A BR 112013013283 A BR112013013283 A BR 112013013283A BR 112013013283 A2 BR112013013283 A2 BR 112013013283A2
- Authority
- BR
- Brazil
- Prior art keywords
- compound
- radiorotulation
- precursor
- preparation
- methods
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B59/00—Introduction of isotopes of elements into organic compounds ; Labelled organic compounds per se
- C07B59/008—Peptides; Proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
- A61K51/082—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins the peptide being a RGD-containing peptide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
- A61K51/088—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins conjugates with carriers being peptides, polyamino acids or proteins
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B59/00—Introduction of isotopes of elements into organic compounds ; Labelled organic compounds per se
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C251/00—Compounds containing nitrogen atoms doubly-bound to a carbon skeleton
- C07C251/32—Oximes
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C259/00—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups
- C07C259/02—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups with replacement of the other oxygen atom of the carboxyl group by halogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/13—Labelling of peptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/531—Production of immunochemical test materials
- G01N33/532—Production of labelled immunochemicals
- G01N33/534—Production of labelled immunochemicals with radioactive label
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/05—Isotopically modified compounds, e.g. labelled
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2318/00—Antibody mimetics or scaffolds
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Molecular Biology (AREA)
- Epidemiology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Optics & Photonics (AREA)
- Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Biomedical Technology (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Analytical Chemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Food Science & Technology (AREA)
- Cell Biology (AREA)
- Biotechnology (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Microbiology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB1020314.9A GB201020314D0 (en) | 2010-12-01 | 2010-12-01 | Apoptosis pet imaging agents |
| US201161476805P | 2011-04-19 | 2011-04-19 | |
| GBGB1106593.5A GB201106593D0 (en) | 2011-04-19 | 2011-04-19 | Radioconjugation method |
| PCT/EP2011/071506 WO2012072736A2 (en) | 2010-12-01 | 2011-12-01 | Radioconjugation method |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR112013013283A2 true BR112013013283A2 (pt) | 2016-11-22 |
Family
ID=45063153
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR112013013283A BR112013013283A2 (pt) | 2010-12-01 | 2011-12-01 | métodos para a radiorrotulação de uma molécula alvo biológica, e de preparação de uma composição radiofarmacêutica, precursor, uso de um aparelho sintetizador automatizado, cassete descartável, composto, e, uso de um composto |
Country Status (12)
| Country | Link |
|---|---|
| US (2) | US9493504B2 (https=) |
| EP (2) | EP2646060B1 (https=) |
| JP (1) | JP6231882B2 (https=) |
| KR (1) | KR20130119957A (https=) |
| CN (2) | CN104984372B (https=) |
| AU (1) | AU2011334881A1 (https=) |
| BR (1) | BR112013013283A2 (https=) |
| CA (1) | CA2819347A1 (https=) |
| ES (2) | ES2675102T3 (https=) |
| MX (1) | MX2013006202A (https=) |
| RU (1) | RU2013122649A (https=) |
| WO (1) | WO2012072736A2 (https=) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2013122649A (ru) * | 2010-12-01 | 2015-01-10 | ДжиИ ХЕЛТКЕР ЛИМИТЕД | Способ радиоактивного коньюгирования |
| GB201314936D0 (en) * | 2013-08-21 | 2013-10-02 | Ge Healthcare Ltd | Radiolabelling method |
| GB201322451D0 (en) * | 2013-12-18 | 2014-02-05 | Ge Healthcare Ltd | Purification method and compositions |
| GB201322456D0 (en) * | 2013-12-18 | 2014-02-05 | Ge Healthcare Ltd | Radiotracer compositions and methods |
| EP3743116B1 (en) * | 2018-01-26 | 2024-07-10 | F. Hoffmann-La Roche AG | Radiolabelled oligonucleotides and process for their preparation |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1996040662A2 (en) * | 1995-06-07 | 1996-12-19 | Cellpro, Incorporated | Aminooxy-containing linker compounds and their application in conjugates |
| GB0305704D0 (en) * | 2003-03-13 | 2003-04-16 | Amersham Plc | Radiofluorination methods |
| WO2005072778A2 (en) * | 2004-01-29 | 2005-08-11 | Biosynexus, Inc. | Use of amino-oxy functional groups in the preparation of vaccines conjugates |
| GB0420344D0 (en) | 2004-09-14 | 2004-10-13 | Amersham Plc | Diagnostic compounds |
| GB0420365D0 (en) | 2004-09-14 | 2004-10-13 | Hammersmith Imanet Ltd | Radiolabelled insulin |
| EP2125039A2 (en) | 2006-12-18 | 2009-12-02 | GE Healthcare AS | Synthesis of a radiofluorinated peptide using photolabile protecting groups |
| EP2114464A2 (en) * | 2006-12-28 | 2009-11-11 | GE Healthcare AS | Radiofluorination methods |
| US8545809B2 (en) * | 2007-01-11 | 2013-10-01 | Immunomedics, Inc. | Methods and compositions for improved 18F labeling of proteins, peptides and other molecules |
| US20080274046A1 (en) * | 2007-02-20 | 2008-11-06 | Christian Prenant | Radiolabelling |
| GB0803477D0 (en) | 2008-02-26 | 2008-04-02 | Ge Healthcare As | Therapy selection method |
| RU2013122649A (ru) * | 2010-12-01 | 2015-01-10 | ДжиИ ХЕЛТКЕР ЛИМИТЕД | Способ радиоактивного коньюгирования |
-
2011
- 2011-12-01 RU RU2013122649/04A patent/RU2013122649A/ru not_active Application Discontinuation
- 2011-12-01 KR KR1020137016889A patent/KR20130119957A/ko not_active Withdrawn
- 2011-12-01 WO PCT/EP2011/071506 patent/WO2012072736A2/en not_active Ceased
- 2011-12-01 AU AU2011334881A patent/AU2011334881A1/en not_active Abandoned
- 2011-12-01 JP JP2013541350A patent/JP6231882B2/ja active Active
- 2011-12-01 US US13/991,340 patent/US9493504B2/en active Active
- 2011-12-01 EP EP11788862.8A patent/EP2646060B1/en active Active
- 2011-12-01 ES ES11788862.8T patent/ES2675102T3/es active Active
- 2011-12-01 CA CA2819347A patent/CA2819347A1/en not_active Abandoned
- 2011-12-01 CN CN201510440109.1A patent/CN104984372B/zh active Active
- 2011-12-01 ES ES18167523T patent/ES2929507T3/es active Active
- 2011-12-01 BR BR112013013283A patent/BR112013013283A2/pt not_active IP Right Cessation
- 2011-12-01 CN CN201180057989.4A patent/CN103269725B/zh active Active
- 2011-12-01 EP EP18167523.2A patent/EP3395373B1/en active Active
- 2011-12-01 MX MX2013006202A patent/MX2013006202A/es unknown
-
2016
- 2016-11-01 US US15/340,743 patent/US20170044080A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| EP2646060B1 (en) | 2018-05-30 |
| AU2011334881A1 (en) | 2013-06-06 |
| CN104984372A (zh) | 2015-10-21 |
| ES2675102T3 (es) | 2018-07-06 |
| CN103269725B (zh) | 2015-09-23 |
| US9493504B2 (en) | 2016-11-15 |
| US20170044080A1 (en) | 2017-02-16 |
| JP6231882B2 (ja) | 2017-11-15 |
| JP2014500883A (ja) | 2014-01-16 |
| CN103269725A (zh) | 2013-08-28 |
| EP3395373A1 (en) | 2018-10-31 |
| EP3395373B1 (en) | 2022-10-19 |
| ES2929507T3 (es) | 2022-11-29 |
| WO2012072736A3 (en) | 2012-10-18 |
| MX2013006202A (es) | 2013-07-29 |
| CN104984372B (zh) | 2018-11-09 |
| US20130259803A1 (en) | 2013-10-03 |
| RU2013122649A (ru) | 2015-01-10 |
| WO2012072736A2 (en) | 2012-06-07 |
| KR20130119957A (ko) | 2013-11-01 |
| EP2646060A2 (en) | 2013-10-09 |
| CA2819347A1 (en) | 2012-06-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR112014003802A2 (pt) | composto, composto composição farmacêutica, uso de um composto, método para fabricar um composto, e, preparação de um medicamento | |
| BR112014016287A2 (pt) | composto, composição farmacêutica, método para aumentar a inclusão de exon 7 de smn2, método para aumentar a quantidade de proteína, método para o tratamento de sma | |
| BR112014007134A2 (pt) | usos de um composto da fórmula (b), compostos, composição farmacêutica, método de preparação do composto e uso de uma quantidade efetiva de um composto | |
| BR112012016398A2 (pt) | Composto imidazopiridinil-aminopiridino substituído, composição farmacêutica que compreende o referido composto e uso do mesmo para o tratamento de uma doença celular proliferativa | |
| BRPI0906475A2 (pt) | Compostos, processso para a preparação de um composto, composição farmacêutica e uso de um composto | |
| BRPI0813237A2 (pt) | Composto, método para preparar o composto, composição, medicamento, e, uso do composto. | |
| BR112014013760A2 (pt) | composto, composição farmacêutica e uso de um composto | |
| HUP1000069A2 (en) | New salts for the preparation of pharmaceutical composition | |
| BR112014011671A2 (pt) | composto, composição farmacêutica, método para o tratamento de uma doença ou condição, e, uso de um composto | |
| BR112012023157A2 (pt) | processos para a preparação de um composto, compostos das fórmulas (llla), (lllb) e (lla), uso de um composto da fórmula (lla) e uso de um reagente de grignard r1mgq | |
| BR112013008259A2 (pt) | composto, composição farmacêutica, e, uso de um composto | |
| BRPI0817423A2 (pt) | Processos para a preparação de um composto, para a preparação de uma formulação farmacêutica, e para a preparação de um intermediário de um composto, e, composto | |
| EP2669289A4 (en) | QUINOLINE-LIKE COMPOUND CONTAINING A PHOSPHORUS-SUBSTITUTED GROUP, PREPARATION METHOD, MEDICAL COMPOSITION CONTAINING THE COMPOUND, AND APPLICATION | |
| BR112013015397A2 (pt) | composto, composição farmacêutica, e, uso de um composto | |
| BR112012027147A2 (pt) | método in vitro destinado à liberação de um composto de vitamina d e à medição de um composto de vitamina d, composição e mistura de reagente, uso de uma composição de reagente e kits | |
| BR112013028959A2 (pt) | composto, processo para o preparo de um composto, combinação de um composto, composição farmacêutica, uso de um composto, dispositivo e kit | |
| BR112014007645A2 (pt) | composto heterocíclico, métodos para a preparação de um composto heterocíclico, e, composição farmacêutica | |
| BR112014005669A2 (pt) | composto, composição farmacêutica e uso de um composto | |
| BR112014003567A2 (pt) | composto, uso de um composto, e, composição farmacêutica | |
| BR112014015042A8 (pt) | composição farmacêutica, e, método para obter uma composição radiofarmacêutica | |
| BR112014009471A2 (pt) | compostos, combinação de um composto, composição farmacêutica, uso de um composto, dispositivo e kit | |
| BR112013013522A2 (pt) | polinucleotídeo ou um sal deste, composição farmacêutica, uso de um polinucleotídeo ou um sal deste, reagente, composição, e, método para produzir um composto | |
| BR112012004173A2 (pt) | "composto, composição, método para preparar uma composição, e, uso de um composto" | |
| BR112014013057A8 (pt) | método para síntese de compostos, e, cassete para realizar o método | |
| BR112013015085A2 (pt) | composição farmacêutica, método para preparar uma composição, e, uso de composição |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] | ||
| B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |